Advertisement
  • Forward Look

    What’s Next?

    Using fecal transplants to improve immunotherapy response

    by Natalie Slivinski

  • Q&A

    Cancer, From the Other Side

    When Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters.

    by Marci A. Landsmann

  • How Long Do Immunotherapy Side Effects Last?

    For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

    by Anna Goshua

  • Facts and Stats

    Categorizing Skin Cancer

    A knowledge of the different types of skin cancer can help you remain vigilant.

    by Bradley Jones

  • Get Involved

    Bringing Joy to the Pediatric Ward

    Students Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients.

    by Bradley Jones

  • Chemobrain: It’s Not Your Imagination

    Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

    by Marci A. Landsmann

  • Survivor Profile

    Breaking Down Barriers

    Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.

    by Bradley Jones

  • Searching the Blood for Signs of Altered Immunity

    The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

    by Kate Yandell

  • March 26: The Week in Cancer News

    Underrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and a study provides new insight into how melanoma metastasizes.

    by Bradley Jones

  • From the Editor-in-Chief

    Cancer in Adolescents and Young Adults

    Patients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.

    by William G. Nelson, MD, PhD